Discover
ACAD
ACADIA Pharmaceuticals Inc.
25.20
1 x 21.86
1 x 28.64
bid
ask
-
0.10
0.40%
1 @ 07:06 AM
25.26 +0.06 (0.24%)
| Ytd | -5.65% | |
| 1y | 17.98% |
24.93
day range
25.55
19.69
52 week range
28.35
| Open | 25.29 | Prev Close | 25.30 | Low | 24.93 | High | 25.55 | Mkt Cap | 4.32B |
| Vol | 1.38M | Avg Vol | 1.71M | EPS | 2.21 | P/E | 11.40 | Forward P/E | 28.55 |
| Beta | 0.83 | Short Ratio | 9.47 | Inst. Own | 99.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 22.05 | 200-d Avg | 23.26 | 1yr Est | 32.00 |
| Income Statement | |||
| Total Revenue | 268.06M | ||
| Revenues (USD) | 268.06M | ||
| Cost of Revenue | 24.79M | ||
| Gross Profit | 243.27M | ||
| Operating Expenses | 247.89M | ||
| Research and Development Expense | 76.87M | ||
| Selling, General and Administrative Expense | 171.02M | ||
| Operating Income | -4.62M | ||
| Income Tax Expense | 344.00K | ||
| Net Income | 3.64M | ||
| Net Income Common Stock | 3.64M | ||
| Net Income Common Stock (USD) | 3.64M | ||
| Consolidated Income | 3.64M | ||
| Earnings per Basic Share | 0.02 | ||
| Earnings per Basic Share (USD) | 0.02 | ||
| Earnings per Diluted Share | 0.02 | ||
| Earning Before Interest & Taxes (EBIT) | 3.98M | ||
| Earning Before Interest & Taxes (USD) | 3.98M | ||
| Weighted Average Shares | 170.52M | ||
| Weighted Average Shares Diluted | 172.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 290.06M | ||
| Cash and Equivalents (USD) | 290.06M | ||
| Investments | 569.25M | ||
| Investments Current | 569.25M | ||
| Trade and Non-Trade Receivables | 148.38M | ||
| Current Assets | 1.10B | ||
| Property, Plant & Equipment Net | 60.93M | ||
| Total Assets | 1.61B | ||
| Total Debt | 39.00M | ||
| Current Liabilities | 305.52M | ||
| Debt Non-Current | 39.00M | ||
| Total Liabilities | 357.16M | ||
| Accumulated Retained Earnings (Deficit) | -1.81B | ||
| Accumulated Other Comprehensive Income | -563.00K | ||
| Shareholders Equity | 1.25B | ||
| Shareholders Equity (USD) | 1.25B | ||
| Assets Non-Current | 509.21M | ||
| Total Debt (USD) | 39.00M | ||
| Goodwill and Intangible Assets | 106.17M | ||
| Inventory | 112.29M | ||
| Liabilities Non-Current | 51.64M | ||
| Trade and Non-Trade Payables | 12.25M | ||
| Tax Assets | 249.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.99M | ||
| Net Cash Flow from Financing | 4.23M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 104.52M | ||
| Capital Expenditure | -5.21M | ||
| Issuance (Purchase) of Equity Shares | 4.23M | ||
| Net Cash Flow from Investing | 66.28M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 71.49M | ||
| Net Cash Flow from Operations | 33.98M | ||
| Effect of Exchange Rate Changes on Cash | 25.00K | ||
| Share Based Compensation | 14.70M | ||